seventy-eight patients with nonseminomatous testicular cancer who had received previous chemotherapy were either treated with ifosfamide/etoposide ( n = 63 , remission rate : 30 % ) or ifosfamide/cisplatin ( n = 15 , cr + pr : 33 % ) .
C0280068
ifosfamide/etoposide
C0020823
ifosfamide